Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5QYD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,206
Award facts
- Contract value 100% obligated
- $23,206.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,206.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pens, a biologic medication used to treat autoimmune and inflammatory conditions. The contract was awarded on January 8, 2026, with an ultimate completion date of January 9, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was awarded on a competitive, non-set-aside basis and represents a task order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government.
This award is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This single-award IDC serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally, covering specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The Defense Logistics Agency relies on such pharmaceutical prime vendor contracts to efficiently supply essential medications to military treatment facilities and veterans' healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F5QYD?
SPE2DR26F5QYD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F5QYD worth?
The government has obligated $23,206 on SPE2DR26F5QYD.
Is contract SPE2DR26F5QYD an order under another contract?
Yes. SPE2DR26F5QYD is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5QYD competed?
The extent of competition for SPE2DR26F5QYD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award